Paper26916628
Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.
Owen A and 1 other. Adv Drug Deliv Rev, 2016. Cited by 140 papers, by iCite.
Cite this record
ConductScience Library. Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy. Papers, record 26916628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26916628
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Delayed-Action Preparations | Major topic |
| HIV Infections | Major topic |
| Anti-HIV Agents | |
| Chemistry, Pharmaceutical | |
| Drug Compounding | |
| Humans |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| G0800247 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| R01 AI114405 | NIAID NIH HHS | United States | R01AI114405 | PubMed and NIH | NIH RePORTER |
| R24 AI118397 | NIAID NIH HHS | United States | R24AI118397 | PubMed and NIH | NIH RePORTER |
| UM1 AI068636 | NIAID NIH HHS | United States | UM1AI068636 | PubMed and NIH | NIH RePORTER |
References146
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19487252 | Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine. | Drug Metab Dispos | 2009 | https://conductscience.org/library/papers/19487252 | PubMed |
| 2 | 23543652 | Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia. | Arch Pharm Res | 2013 | https://conductscience.org/library/papers/23543652 | PubMed |
| 3 | 24920821 | Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance. | J Virol | 2014 | https://conductscience.org/library/papers/24920821 | PubMed |
| 4 | 2563168 | Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2563168 | PubMed |
| 5 | 20033474 | Improved lysozyme stability and release properties of poly(lactide-co-glycolide) implants prepared by hot-melt extrusion. | Pharm Res | 2010 | https://conductscience.org/library/papers/20033474 | PubMed |
| 6 | 20727929 | Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. | J Control Release | 2010 | https://conductscience.org/library/papers/20727929 | PubMed |
| 7 | 25899076 | Long-acting injectable hormonal dosage forms for contraception. | Pharm Res | 2015 | https://conductscience.org/library/papers/25899076 | PubMed |
| 8 | 14680467 | Microspheres for controlled release drug delivery. | Expert Opin Biol Ther | 2004 | https://conductscience.org/library/papers/14680467 | PubMed |
| 9 | 10981882 | Insulin glargine. | Lancet | 2000 | https://conductscience.org/library/papers/10981882 | PubMed |
| 10 | 19940267 | Human skeletal muscle drug transporters determine local exposure and toxicity of statins. | Circ Res | 2010 | https://conductscience.org/library/papers/19940267 | PubMed |
| 11 | 26070249 | A science based approach to topical drug classification system (TCS). | Int J Pharm | 2015 | https://conductscience.org/library/papers/26070249 | PubMed |
| 12 | 17272818 | Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. | Circ Res | 2007 | https://conductscience.org/library/papers/17272818 | PubMed |
| 13 | 10390517 | Microvascular permeability. | Physiol Rev | 1999 | https://conductscience.org/library/papers/10390517 | PubMed |
| 14 | 15964286 | The acceptability of self-administration of subcutaneous Depo-Provera. | Contraception | 2005 | https://conductscience.org/library/papers/15964286 | PubMed |
| 15 | 17329995 | CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavir. | Clin Pharmacol Ther | 2007 | https://conductscience.org/library/papers/17329995 | PubMed |
| 16 | 26195515 | Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26195515 | PubMed |
| 17 | 23410799 | Injectable implants for the sustained release of protein and peptide drugs. | Drug Discov Today | 2013 | https://conductscience.org/library/papers/23410799 | PubMed |
| 18 | 18672949 | Factors affecting the clearance and biodistribution of polymeric nanoparticles. | Mol Pharm | 2008 | https://conductscience.org/library/papers/18672949 | PubMed |
| 19 | 22167349 | Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells. | Pharm Res | 2012 | https://conductscience.org/library/papers/22167349 | PubMed |
| 20 | 17289316 | Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory. | Int J Pharm | 2007 | https://conductscience.org/library/papers/17289316 | PubMed |
Cited by87
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942853 | Toward Long-Acting Injectable Antidepressants: Drug-Delivery Strategies, Clinical Considerations, and Regulatory Barriers. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942853 | PubMed |
| 42629977 | Making the Case for Organ-on-Chip Platforms in Long-Acting Therapeutics Development. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42629977 | PubMed |
| 41704016 | Accelerating Generic Long-Acting Antiretrovirals for Global HIV Treatment: Workshop Findings and a Roadmap to Access. | Clin Pharmacol Ther | 2026 | https://conductscience.org/library/papers/41704016 | PubMed |
| 41141445 | Exploring the Interaction Between Injection Site and Biological Sex on the Real-world Population Pharmacokinetics of Long-acting Cabotegravir and Rilpivirine in People With HIV. | Open Forum Infect Dis | 2025 | https://conductscience.org/library/papers/41141445 | PubMed |
| 41121455 | Polypharmacy in HIV: Rethinking what counts and why it matters. | HIV Med | 2026 | https://conductscience.org/library/papers/41121455 | PubMed |
| 40870981 | Recent Advances in Donepezil Delivery Systems via the Nose-to-Brain Pathway. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40870981 | PubMed |
| 40577227 | Long-acting Injectable Containing Lopinavir Eliminates Reliance on Ritonavir Pharmacokinetic Enhancement. | J Infect Dis | 2025 | https://conductscience.org/library/papers/40577227 | PubMed |
| 40574047 | The Impact of a Manufacturing Process on the Stability of Microcrystalline Long-Acting Injections: A Case Study on Aripiprazole Monohydrate. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40574047 | PubMed |
| 40544972 | Improving in vivo release prediction from in situ forming depots with a novel flow-through in vitro dissolution apparatus. | Int J Pharm | 2025 | https://conductscience.org/library/papers/40544972 | PubMed |
| 40430917 | Unveiling the Future: Opportunities in Long-Acting Injectable Drug Development for Veterinary Care. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40430917 | PubMed |
| 40284990 | Elevated Methylglyoxal: An Elusive Risk Factor Responsible for Early-Onset Cardiovascular Diseases in People Living with HIV-1 Infection. | Viruses | 2025 | https://conductscience.org/library/papers/40284990 | PubMed |
| 40268201 | PLGA-based long-acting injectable (LAI) formulations. | J Control Release | 2025 | https://conductscience.org/library/papers/40268201 | PubMed |
| 39840486 | Delivery of Islatravir via High Drug-Load, Long-acting Microarray Patches for the Prevention or Treatment of Human Immunodeficiency Virus. | Adv Healthc Mater | 2025 | https://conductscience.org/library/papers/39840486 | PubMed |
| 39771474 | Two in One: Size Characterization and Accelerated Short-Term Physical Stability of Dual-Drug Suspensions with Two Acidic Compounds (Indomethacin and Naproxen). | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39771474 | PubMed |
| 39483451 | State of the ART (antiretroviral therapy): Long-acting HIV-1 therapeutics. | Glob Health Med | 2024 | https://conductscience.org/library/papers/39483451 | PubMed |
| 39225461 | Novel pH-Responsive Structural Rearrangement of Myristic Acid-Conjugated Quetiapine Nanosuspension for Enhanced Long-Acting Delivery Performance. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39225461 | PubMed |
| 39160132 | Patient-Centric Long-Acting Injectable and Implantable Platforms─An Industrial Perspective. | Mol Pharm | 2024 | https://conductscience.org/library/papers/39160132 | PubMed |
| 39065593 | Physiologically-Based Pharmacokinetic Modeling and In Vitro-In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39065593 | PubMed |
| 39036080 | Tricaprylin-based drug crystalline suspension for intramuscular long-acting delivery of entecavir with alleviated local inflammation. | Bioeng Transl Med | 2024 | https://conductscience.org/library/papers/39036080 | PubMed |
| 38543270 | Continuous Microfluidic Antisolvent Crystallization as a Bottom-Up Solution for the Development of Long-Acting Injectable Formulations. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38543270 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26916628
GET https://conductscience.org/api/papers/v1/26916628/references?page=2